Early and late outcomes of single versus bilateral internal thoracic artery revascularization for patients in critical condition.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 23 05 2021
accepted: 22 07 2021
entrez: 5 8 2021
pubmed: 6 8 2021
medline: 15 12 2021
Statut: epublish

Résumé

The optimal surgical approach for critically ill patients with complex coronary disease remains uncertain. We compared outcomes of bilateral internal thoracic artery (BITA) versus single ITA (SITA) revascularization in critical patients. We evaluated 394 consecutive critical patients with multi-vessel disease who underwent CABG during 1996-2001. Outcomes measured were early mortality, strokes, myocardial-infarctions, sternal infections, revisions for bleeding, and late survival. The critical preoperative state was acknowledged concisely by one or more of the following: preoperative ventricular tachycardia/fibrillation, aborted sudden cardiac death, or the need for mechanical ventilation or for preoperative insertion of intra-aortic-balloon counter-pulsation. During the study period, 193 of our patients who underwent SITA and 201 who underwent BITA were in critical condition. The SITA group was older (mean 68.0 vs. 63.3 years, p = 0.001) and higher proportions were females (28.5% vs. 18.9% p = 0.025), after recent-MI (69.9% vs. 57.2% p = 0.009) and with left-main disease (38.3% vs. 49.3% p = .029); the median logistic EuroSCORE was higher (0.2898 vs. 0.1597, p<0.001). No statistically significant differences were observed between the SITA and BITA groups in 30-day mortality; and in rates of early CVA, MI and sternal infections (13.0% vs. 8.5%, p = 0.148; 4.1% vs. 6.0%, p = 0.49; 6.7% vs. 4.5%, p = 0.32 and 2.1% vs. 2.5%, p>0.99, respectively). Long-term survival (median follow-up of 15 years, interquartile-range: 13.57-15) was better in the BITA group (median 14.39 vs. 9.31± 0.9 years, p = 0.001). Propensity-score matching (132 matched pairs) also yielded similar early outcomes and improved long-term survival (median follow-up of 15 years, interquartile-range: 13.56-15) for the BITA group (median 12.49±1.71 vs. 7.63±0.99 years, p = 0.002). In multivariable analysis, BITA revascularization was found to be a predictor for improved survival (hazard-ratio of 0.419, 95%CI 0.23-0.76, p = 0.004). This study demonstrated long-term survival benefit for BITA revascularization in patients in a critical pre-operative state who presented for surgical revascularization.

Identifiants

pubmed: 34352035
doi: 10.1371/journal.pone.0255740
pii: PONE-D-21-16959
pmc: PMC8341519
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0255740

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circulation. 2008 Aug 12;118(7):705-12
pubmed: 18663087
J Am Coll Cardiol. 2001 Feb;37(2):521-8
pubmed: 11216973
J Cardiothorac Surg. 2013 Jul 03;8:167
pubmed: 23819483
Circulation. 1998 Nov 10;98(19 Suppl):II1-6
pubmed: 9852872
Ann Thorac Surg. 2004 Dec;78(6):2005-12; discussion 2012-4
pubmed: 15561021
Eur J Cardiothorac Surg. 1999 Jun;15(6):816-22; discussion 822-3
pubmed: 10431864
Lancet. 2001 Sep 15;358(9285):870-5
pubmed: 11567701
Circulation. 2011 Sep 20;124(12):1321-9
pubmed: 21900082
J Thorac Cardiovasc Surg. 2014 Nov;148(5):1869-75
pubmed: 24521970
Tex Heart Inst J. 2016 Jun 01;43(3):214-9
pubmed: 27303236
Eur J Cardiothorac Surg. 2019 Nov 1;56(5):935-941
pubmed: 30957860
Circulation. 2004 Sep 14;110(11 Suppl 1):II27-35
pubmed: 15364834
Eur J Cardiothorac Surg. 2002 Nov;22(5):781-6
pubmed: 12414046
J Thorac Cardiovasc Surg. 2020 Mar 19;:
pubmed: 32305186
Ann Thorac Surg. 2009 Dec;88(6):1786-92
pubmed: 19932235
Circulation. 2014 Aug 12;130(7):539-45
pubmed: 24916209
N Engl J Med. 1986 Jan 2;314(1):1-6
pubmed: 3484393
Circulation. 2006 Jul 4;114(1 Suppl):I477-85
pubmed: 16820622
Ann Thorac Surg. 2001 Nov;72(5):1535-41
pubmed: 11722039
Ann Thorac Surg. 2000 Mar;69(3):841-6
pubmed: 10750770
Ann Thorac Surg. 2016 Mar;101(3):960-6
pubmed: 26518374
Ann Thorac Surg. 2020 Dec 27;:
pubmed: 33378695
Chest. 2003 May;123(5):1348-54
pubmed: 12740246
Eur J Cardiothorac Surg. 2016 May;49(5):1451-6
pubmed: 26582345
J Card Surg. 2020 Aug;35(8):1958-1978
pubmed: 32643847
Am J Cardiol. 2015 Oct 15;116(8):1193-8
pubmed: 26303635
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1031-1040
pubmed: 29059371
J Am Heart Assoc. 2017 Jul 21;6(7):
pubmed: 28733432
J Thorac Cardiovasc Surg. 2001 Apr;121(4):668-74
pubmed: 11279406
J Thorac Cardiovasc Surg. 1999 May;117(5):855-72
pubmed: 10220677

Auteurs

Michal Fertouk (M)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Amit Gordon (A)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dmitry Pevni (D)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Tomer Ziv-Baran (T)

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Orr Sela (O)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Rephael Mohr (R)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ariel Farkash (A)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Amir Kramer (A)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nadav Teich (N)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nachum Nesher (N)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yanai Ben-Gal (Y)

Department of Cardiothoracic Surgery, Tel-Aviv Sourasky Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH